Wikiwand AI

Leucine–tRNA ligase, mitochondrial

Enzyme found in humans From Wikipedia, the free encyclopedia

Leucine–tRNA ligase, mitochondrial, also called leucyl-tRNA synthetase 2, mitochondrial, is an enzyme that in humans is encoded by the LARS2 gene.[5][6] Like leucine–tRNA ligase, cytoplasmic (LARS1), this enzyme functions as a leucine–tRNA ligase,[7] meaning it binds the amino acid leucine to the corresponding transfer RNA, tRNALeu, as part of protein synthesis.[6]

AliasesLARS2, LEURS, PRLTS4, mtLeuRS, leucyl-tRNA synthetase 2, mitochondrial, HLASA
End45,554,726 bp[1]
Quick facts LARS2, Identifiers ...
LARS2
Identifiers
AliasesLARS2, LEURS, PRLTS4, mtLeuRS, leucyl-tRNA synthetase 2, mitochondrial, HLASA
External IDsOMIM: 604544; MGI: 2142973; GeneCards: LARS2
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
6.1.1.4↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_015340
NM_001368263

NM_153168
NM_001348167
NM_001348168

RefSeq (protein)

NP_056155
NP_001355192

NP_694808
NP_001335096
NP_001335097

Location (UCSC)Chr 3: 45.39 – 45.55 MbChr 9: 123.2 – 123.29 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse
Close

Function

This enzyme is a class 1 aminoacyl-tRNA synthetase. It participates in RNA-to-protein translation by binding the amino acid leucine to the corresponding transfer RNA, tRNALeu.[6]

Medical significance

Pathogenic (homozygous or compound heterozygous) mutations in LARS2 are associated with deafness and ovarian disgenesis, called Perrault syndrome-4 (PRLTS4).[8] In some cases, people with certain pathogenic (compound heterozygous) mutations suffer from more severe symptoms starting in the womb such as anemia and hydrops (fluid build-up), and breathing difficulties after birth which can lead to death. This more severe syndrome is called hydrops, lactic acidosis, and sideroblastic anemia (HLASA)[9]

References

Further reading

Related Articles

Timelines

Top Qs

Fact Checks